Altresyn® (altrenogest) rebranded OvaMed™ following product acquisition from Ceva Animal Health
Oakbrook Terrace, Ill.; March 1st, 2017 – Bimeda Inc. is pleased to announce the renaming of its altrenogest product for horses.
The product, formerly marketed as Altresyn® was recently acquired from Ceva Animal Health as part of Bimeda’s strategic expansion into the equine segment.
“The trade name OvaMed™ more closely aligns with Bimeda’s brand identity and is a key step in the integration of the recently-acquired equine products within our portfolio and global brand” said Emmanuelle Lemaire-Galliot, Marketing Manager for Bimeda North America.
OvaMed™ is currently shipping to Bimeda’s distributors to fulfill veterinary orders.
For more information, visit www.bimedaus.com and www.bimedaequine.com
News from the horse industry. Sharing today’s information as it happens. The Northwest Horse Source is not responsible for the content of 3rd party submissions.
